Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 28 | 2025 | 384 | 6.360 |
Why?
|
| Nucleus Accumbens | 12 | 2023 | 45 | 3.710 |
Why?
|
| Fentanyl | 4 | 2025 | 76 | 2.580 |
Why?
|
| Substance Withdrawal Syndrome | 5 | 2025 | 123 | 2.410 |
Why?
|
| Analgesics, Opioid | 10 | 2025 | 536 | 2.210 |
Why?
|
| Sleep | 5 | 2025 | 226 | 2.090 |
Why?
|
| Opioid-Related Disorders | 5 | 2025 | 509 | 2.000 |
Why?
|
| Cocaine | 8 | 2023 | 101 | 1.810 |
Why?
|
| Sex Characteristics | 9 | 2021 | 203 | 1.560 |
Why?
|
| Sleep Wake Disorders | 4 | 2025 | 73 | 1.530 |
Why?
|
| Substance-Related Disorders | 6 | 2024 | 737 | 1.230 |
Why?
|
| Mice, Inbred C57BL | 15 | 2025 | 3398 | 1.210 |
Why?
|
| Ethanol | 9 | 2020 | 322 | 1.190 |
Why?
|
| Animals | 47 | 2025 | 20695 | 1.140 |
Why?
|
| Reward | 8 | 2022 | 87 | 1.080 |
Why?
|
| Corpus Striatum | 5 | 2025 | 97 | 1.070 |
Why?
|
| Mice | 31 | 2025 | 10848 | 1.060 |
Why?
|
| Neonatal Abstinence Syndrome | 2 | 2025 | 38 | 1.040 |
Why?
|
| Killer Cells, Natural | 3 | 2013 | 217 | 1.000 |
Why?
|
| Period Circadian Proteins | 3 | 2015 | 73 | 0.930 |
Why?
|
| Motor Activity | 7 | 2015 | 346 | 0.930 |
Why?
|
| Glycerides | 1 | 2024 | 11 | 0.870 |
Why?
|
| Arachidonic Acids | 1 | 2024 | 27 | 0.860 |
Why?
|
| Endocannabinoids | 1 | 2024 | 22 | 0.860 |
Why?
|
| Circadian Clocks | 3 | 2017 | 49 | 0.820 |
Why?
|
| Chronobiology Disorders | 2 | 2014 | 6 | 0.810 |
Why?
|
| Brain | 8 | 2023 | 1556 | 0.790 |
Why?
|
| Stress, Psychological | 2 | 2019 | 474 | 0.790 |
Why?
|
| Prefrontal Cortex | 5 | 2023 | 121 | 0.790 |
Why?
|
| Alcohol Drinking | 6 | 2018 | 314 | 0.770 |
Why?
|
| Hormones | 2 | 2021 | 60 | 0.760 |
Why?
|
| Analgesia | 1 | 2022 | 31 | 0.750 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2020 | 149 | 0.720 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2022 | 124 | 0.720 |
Why?
|
| Male | 39 | 2025 | 30008 | 0.700 |
Why?
|
| Valproic Acid | 1 | 2020 | 24 | 0.670 |
Why?
|
| Nerve Tissue Proteins | 6 | 2022 | 424 | 0.650 |
Why?
|
| Sirtuin 1 | 3 | 2022 | 26 | 0.630 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2025 | 35 | 0.630 |
Why?
|
| Depressive Disorder, Major | 3 | 2020 | 248 | 0.620 |
Why?
|
| Neurons | 6 | 2025 | 922 | 0.620 |
Why?
|
| Aggression | 1 | 2019 | 64 | 0.600 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2019 | 5 | 0.600 |
Why?
|
| Fibroblasts | 1 | 2021 | 394 | 0.600 |
Why?
|
| Transcription Factors | 4 | 2022 | 1513 | 0.580 |
Why?
|
| Depression | 3 | 2024 | 908 | 0.570 |
Why?
|
| Dopamine | 4 | 2025 | 107 | 0.560 |
Why?
|
| Brain Diseases | 1 | 2019 | 78 | 0.550 |
Why?
|
| Longevity | 1 | 2019 | 113 | 0.550 |
Why?
|
| Vulnerable Populations | 1 | 2017 | 89 | 0.520 |
Why?
|
| Antipsychotic Agents | 4 | 2024 | 301 | 0.520 |
Why?
|
| beta-Endorphin | 2 | 2015 | 8 | 0.480 |
Why?
|
| Anxiety | 3 | 2020 | 429 | 0.480 |
Why?
|
| Female | 25 | 2025 | 33026 | 0.470 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2015 | 20 | 0.460 |
Why?
|
| Dopaminergic Neurons | 4 | 2025 | 38 | 0.440 |
Why?
|
| Spleen | 2 | 2013 | 483 | 0.440 |
Why?
|
| Schizophrenia | 3 | 2022 | 263 | 0.430 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 1618 | 0.430 |
Why?
|
| Humans | 31 | 2025 | 63643 | 0.420 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2015 | 143 | 0.420 |
Why?
|
| CLOCK Proteins | 4 | 2018 | 47 | 0.410 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2015 | 156 | 0.400 |
Why?
|
| Granzymes | 1 | 2013 | 21 | 0.400 |
Why?
|
| Wakefulness | 2 | 2024 | 43 | 0.400 |
Why?
|
| Perforin | 1 | 2013 | 31 | 0.400 |
Why?
|
| Transcriptome | 6 | 2024 | 386 | 0.390 |
Why?
|
| Disease Models, Animal | 6 | 2025 | 2196 | 0.390 |
Why?
|
| Proteome | 2 | 2023 | 150 | 0.380 |
Why?
|
| Psychotic Disorders | 2 | 2024 | 158 | 0.370 |
Why?
|
| Behavior | 1 | 2012 | 36 | 0.370 |
Why?
|
| Mice, Inbred C3H | 1 | 2011 | 176 | 0.360 |
Why?
|
| Aging | 3 | 2025 | 745 | 0.350 |
Why?
|
| Rats | 7 | 2021 | 1982 | 0.340 |
Why?
|
| Interferon-gamma | 1 | 2013 | 567 | 0.340 |
Why?
|
| Sympathetic Nervous System | 1 | 2010 | 35 | 0.330 |
Why?
|
| Immune System | 1 | 2011 | 130 | 0.330 |
Why?
|
| Computational Biology | 1 | 2012 | 355 | 0.310 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 770 | 0.300 |
Why?
|
| Cocaine-Related Disorders | 2 | 2020 | 82 | 0.300 |
Why?
|
| Metabolic Diseases | 2 | 2021 | 58 | 0.280 |
Why?
|
| Biological Clocks | 3 | 2009 | 70 | 0.250 |
Why?
|
| Inflammation | 2 | 2025 | 1147 | 0.250 |
Why?
|
| Animals, Newborn | 2 | 2025 | 239 | 0.240 |
Why?
|
| Glutamic Acid | 3 | 2022 | 99 | 0.240 |
Why?
|
| Receptors, Serotonin, 5-HT4 | 1 | 2025 | 1 | 0.240 |
Why?
|
| Serotonin 5-HT4 Receptor Agonists | 1 | 2025 | 1 | 0.240 |
Why?
|
| Benzofurans | 1 | 2025 | 11 | 0.240 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 2 | 2025 | 4 | 0.240 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2025 | 37 | 0.230 |
Why?
|
| Extraembryonic Membranes | 1 | 2025 | 5 | 0.230 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 684 | 0.230 |
Why?
|
| Locomotion | 3 | 2021 | 116 | 0.230 |
Why?
|
| Mesencephalon | 1 | 2025 | 28 | 0.230 |
Why?
|
| Sequence Analysis, RNA | 3 | 2021 | 174 | 0.220 |
Why?
|
| Behavior, Animal | 2 | 2018 | 230 | 0.220 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2025 | 87 | 0.220 |
Why?
|
| Mental Disorders | 1 | 2012 | 795 | 0.210 |
Why?
|
| Central Nervous System Depressants | 4 | 2015 | 46 | 0.210 |
Why?
|
| Premature Birth | 1 | 2025 | 112 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 699 | 0.200 |
Why?
|
| Suicidal Ideation | 1 | 2024 | 118 | 0.200 |
Why?
|
| Morphine | 1 | 2023 | 59 | 0.200 |
Why?
|
| Ketamine | 1 | 2023 | 38 | 0.200 |
Why?
|
| Macaca mulatta | 1 | 2024 | 256 | 0.200 |
Why?
|
| Periodicity | 1 | 2023 | 49 | 0.200 |
Why?
|
| Metformin | 1 | 2024 | 74 | 0.190 |
Why?
|
| Hyperalgesia | 1 | 2022 | 15 | 0.190 |
Why?
|
| Cytokines | 2 | 2021 | 934 | 0.190 |
Why?
|
| Drug Tolerance | 1 | 2022 | 33 | 0.190 |
Why?
|
| Arousal | 1 | 2022 | 42 | 0.190 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 359 | 0.190 |
Why?
|
| NAD | 2 | 2022 | 53 | 0.180 |
Why?
|
| Analgesics | 1 | 2022 | 102 | 0.180 |
Why?
|
| Buprenorphine | 1 | 2025 | 193 | 0.180 |
Why?
|
| Ventral Tegmental Area | 2 | 2020 | 38 | 0.180 |
Why?
|
| Electroencephalography | 1 | 2022 | 150 | 0.180 |
Why?
|
| Hypothalamus | 2 | 2012 | 132 | 0.180 |
Why?
|
| Vesicular Glutamate Transport Proteins | 1 | 2021 | 1 | 0.180 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2023 | 98 | 0.180 |
Why?
|
| Eye Movements | 1 | 2022 | 83 | 0.180 |
Why?
|
| Parkinsonian Disorders | 1 | 2021 | 15 | 0.180 |
Why?
|
| Astrocytes | 1 | 2022 | 119 | 0.170 |
Why?
|
| Glucagon | 1 | 2021 | 33 | 0.170 |
Why?
|
| Genetics | 1 | 2021 | 13 | 0.170 |
Why?
|
| Models, Biological | 4 | 2017 | 1181 | 0.170 |
Why?
|
| Histone Deacetylase 2 | 1 | 2020 | 17 | 0.170 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 32 | 0.170 |
Why?
|
| Nerve Degeneration | 1 | 2021 | 72 | 0.170 |
Why?
|
| Neurosciences | 1 | 2021 | 27 | 0.170 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 36 | 0.170 |
Why?
|
| Mutation | 3 | 2020 | 2614 | 0.170 |
Why?
|
| Insulin | 3 | 2023 | 686 | 0.160 |
Why?
|
| Insulin Resistance | 1 | 2023 | 412 | 0.160 |
Why?
|
| Species Specificity | 3 | 2020 | 334 | 0.160 |
Why?
|
| Pregnancy Complications | 1 | 2025 | 378 | 0.160 |
Why?
|
| Molecular Biology | 1 | 2021 | 67 | 0.160 |
Why?
|
| Drinking | 2 | 2018 | 14 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 542 | 0.160 |
Why?
|
| Blotting, Western | 2 | 2012 | 612 | 0.160 |
Why?
|
| Pain | 1 | 2022 | 407 | 0.160 |
Why?
|
| Software | 1 | 2023 | 388 | 0.150 |
Why?
|
| Social Behavior | 1 | 2019 | 89 | 0.150 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 175 | 0.150 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 722 | 0.140 |
Why?
|
| Conditioning, Operant | 1 | 2018 | 27 | 0.140 |
Why?
|
| Clozapine | 1 | 2018 | 32 | 0.140 |
Why?
|
| Receptors, Dopamine | 1 | 2017 | 16 | 0.140 |
Why?
|
| Genotype | 1 | 2020 | 662 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 150 | 0.140 |
Why?
|
| Synapses | 1 | 2019 | 184 | 0.130 |
Why?
|
| Lithium | 1 | 2017 | 21 | 0.130 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 326 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 883 | 0.120 |
Why?
|
| Norepinephrine | 2 | 2021 | 103 | 0.120 |
Why?
|
| Mood Disorders | 1 | 2016 | 72 | 0.120 |
Why?
|
| Drosophila Proteins | 1 | 2021 | 688 | 0.120 |
Why?
|
| Fasting | 1 | 2015 | 51 | 0.120 |
Why?
|
| Self Administration | 3 | 2020 | 48 | 0.120 |
Why?
|
| Dopamine Uptake Inhibitors | 3 | 2020 | 25 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 263 | 0.120 |
Why?
|
| Synaptic Transmission | 3 | 2022 | 149 | 0.120 |
Why?
|
| Lithium Chloride | 1 | 2015 | 11 | 0.120 |
Why?
|
| Corticosterone | 1 | 2015 | 23 | 0.110 |
Why?
|
| Body Temperature | 1 | 2015 | 45 | 0.110 |
Why?
|
| Antimanic Agents | 1 | 2015 | 31 | 0.110 |
Why?
|
| Running | 1 | 2015 | 84 | 0.110 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2015 | 24 | 0.110 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 158 | 0.110 |
Why?
|
| Maze Learning | 1 | 2015 | 55 | 0.110 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2015 | 34 | 0.110 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 246 | 0.110 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 189 | 0.110 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 183 | 0.110 |
Why?
|
| Restraint, Physical | 1 | 2015 | 41 | 0.110 |
Why?
|
| Amygdala | 1 | 2015 | 83 | 0.110 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 2 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2025 | 1276 | 0.110 |
Why?
|
| Adolescent | 3 | 2024 | 6260 | 0.100 |
Why?
|
| Pregnancy | 2 | 2025 | 2338 | 0.100 |
Why?
|
| ARNTL Transcription Factors | 1 | 2013 | 26 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2015 | 484 | 0.100 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 302 | 0.100 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 53 | 0.090 |
Why?
|
| Photoperiod | 1 | 2012 | 42 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 878 | 0.090 |
Why?
|
| Work Schedule Tolerance | 1 | 2011 | 22 | 0.090 |
Why?
|
| Autonomic Nervous System | 1 | 2011 | 36 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 206 | 0.090 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 158 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 299 | 0.090 |
Why?
|
| Sympathectomy, Chemical | 1 | 2010 | 1 | 0.090 |
Why?
|
| Guanethidine | 1 | 2010 | 3 | 0.090 |
Why?
|
| Sympatholytics | 1 | 2010 | 5 | 0.080 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 163 | 0.080 |
Why?
|
| Time Factors | 3 | 2015 | 3770 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 618 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 642 | 0.070 |
Why?
|
| Rats, Long-Evans | 2 | 2005 | 22 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2025 | 2158 | 0.070 |
Why?
|
| RNA | 1 | 2010 | 425 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2019 | 1121 | 0.060 |
Why?
|
| Cosmetics | 1 | 2005 | 17 | 0.060 |
Why?
|
| Terpenes | 1 | 2005 | 27 | 0.060 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2025 | 86 | 0.060 |
Why?
|
| Alcoholism | 2 | 2024 | 317 | 0.050 |
Why?
|
| Seizures | 1 | 2005 | 143 | 0.050 |
Why?
|
| Adult | 4 | 2025 | 16902 | 0.050 |
Why?
|
| Suicide, Attempted | 1 | 2024 | 107 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2025 | 320 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2025 | 344 | 0.050 |
Why?
|
| Fear | 1 | 2023 | 70 | 0.050 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2025 | 258 | 0.050 |
Why?
|
| Workflow | 1 | 2023 | 71 | 0.050 |
Why?
|
| Brain Stem | 1 | 2021 | 28 | 0.050 |
Why?
|
| Hippocampus | 1 | 2023 | 270 | 0.040 |
Why?
|
| Rotenone | 1 | 2021 | 10 | 0.040 |
Why?
|
| Rats, Inbred Lew | 1 | 2021 | 106 | 0.040 |
Why?
|
| Adrenergic Agents | 1 | 2021 | 15 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2025 | 334 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 5502 | 0.040 |
Why?
|
| Glucose | 1 | 2024 | 467 | 0.040 |
Why?
|
| Insecticides | 1 | 2021 | 44 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2020 | 64 | 0.040 |
Why?
|
| Synaptic Vesicles | 1 | 2020 | 25 | 0.040 |
Why?
|
| Rodentia | 1 | 2020 | 22 | 0.040 |
Why?
|
| Pancreas | 1 | 2021 | 154 | 0.040 |
Why?
|
| Anhedonia | 1 | 2020 | 6 | 0.040 |
Why?
|
| Gonadal Hormones | 1 | 2020 | 5 | 0.040 |
Why?
|
| Light | 2 | 2015 | 202 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2020 | 60 | 0.040 |
Why?
|
| Biological Transport | 1 | 2020 | 291 | 0.040 |
Why?
|
| Nerve Net | 1 | 2020 | 97 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 88 | 0.040 |
Why?
|
| Cell Survival | 1 | 2021 | 576 | 0.040 |
Why?
|
| Behavior, Addictive | 1 | 2020 | 73 | 0.040 |
Why?
|
| Middle Aged | 3 | 2025 | 17711 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2025 | 1536 | 0.040 |
Why?
|
| Affect | 1 | 2020 | 127 | 0.040 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2018 | 1 | 0.040 |
Why?
|
| Receptor, Muscarinic M4 | 1 | 2018 | 2 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2018 | 38 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2018 | 64 | 0.030 |
Why?
|
| Drosophila | 1 | 2021 | 434 | 0.030 |
Why?
|
| Action Potentials | 1 | 2018 | 105 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2018 | 127 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 215 | 0.030 |
Why?
|
| Neuroglia | 1 | 2018 | 79 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 2586 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 2017 | 76 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2021 | 1363 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 768 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 152 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 2015 | 43 | 0.030 |
Why?
|
| Proteomics | 1 | 2017 | 283 | 0.030 |
Why?
|
| Aged | 2 | 2025 | 14524 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 297 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 840 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 2110 | 0.030 |
Why?
|
| Genome, Human | 1 | 2015 | 237 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 576 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 456 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 2576 | 0.020 |
Why?
|
| Algorithms | 1 | 2018 | 1005 | 0.020 |
Why?
|
| alpha-MSH | 1 | 2012 | 3 | 0.020 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2012 | 7 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2012 | 14 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2012 | 34 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 72 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2018 | 879 | 0.020 |
Why?
|
| United States | 1 | 2024 | 7868 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 1567 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 609 | 0.020 |
Why?
|
| Triazolam | 1 | 2007 | 4 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 2007 | 18 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2007 | 94 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2007 | 156 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2007 | 90 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2007 | 66 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2007 | 76 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 367 | 0.020 |
Why?
|
| Camphor | 1 | 2005 | 1 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 4717 | 0.010 |
Why?
|
| Chronobiology Phenomena | 1 | 2005 | 2 | 0.010 |
Why?
|
| Activity Cycles | 1 | 2005 | 3 | 0.010 |
Why?
|
| Intellectual Disability | 1 | 2005 | 168 | 0.010 |
Why?
|
| Infant | 1 | 2005 | 1654 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2005 | 1999 | 0.010 |
Why?
|